Why it was recalled
Failed Impurities/Degradation Specifications
Product description
Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial, Rx Only, Manufactured by: OneSource Specialty, Pharma Limited, Bengaluru - 561 203, India, Manufactured for: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-893-31
Lot numbers, UPCs & expiration codes
Lot #: 7000612A, Exp. Date 1/2028
Where it was sold
Nationwide within the United States
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0662-2026
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- Jun 7, 2026
- FDA report date
- Jul 15, 2026
- Quantity
- 4284 vials
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- ONESOURCE SPECIALTY PHARMA LIMITED
Original FDA data
Every field from FDA enforcement report D-0662-2026, exactly as published.
Show all FDA fields
- City
- Bengaluru
- Status
- Ongoing
- Country
- India
- Event ID
- 99220
- Address
- Plot No.: 2-D1, Obadenahalli Industrial Area, Doddaballapura
- Address (line 2)
- 3rd Phase; Kasa, Doddaballapura Taluk
- Code information
- Lot #: 7000612A, Exp. Date 1/2028
- Report date
- Jul 15, 2026
- Product type
- Drugs
- Recall number
- D-0662-2026
- Classification
- Class II
- Recalling firm
- ONESOURCE SPECIALTY PHARMA LIMITED
- Product quantity
- 4284 vials
- Reason for recall
- Failed Impurities/Degradation Specifications
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial, Rx Only, Manufactured by: OneSource Specialty, Pharma Limited, Bengaluru - 561 203, India, Manufactured for: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-893-31
- Distribution pattern
- Nationwide within the United States
- Recall initiation date
- Jun 7, 2026
- Initial firm notification
- Letter
- Center classification date
- Jul 7, 2026